We wish to thank the following sponsors for their generous support:
Level 1Abbott - higher res.jpg Abbott is a global healthcare company devoted to improving patient’s lives. With the recent acquisition of St. Jude Medical we now offer the most comprehensive set of solutions in coronary, CRM, EP, heart failure, structural heart, vascular and endovascular. Our breadth and depth of industry-leading technologies bring you end-to end solutions and services. abbott.comAmgenCardiology.jpg
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com www.amgen.comAstrazeneca High Res.JPG AstraZeneca is a global, science-led biopharmaceutical company that spans discovery, development, manufacturing, distribution and worldwide commercialisation. We invest in distinctive science in three main therapeutic areas; Oncology; Respiratory, Inflammation and Autoimmunity (RIA); Cardiovascular and Metabolic diseases (CVMD) and our science exploits our rare combination of capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. AstraZeneca Australia supplies medicines to 22 countries including Australia and New Zealand. www.astrazeneca.com.auBayer.jpg Bayer is an international, research-based enterprise with core competencies in health care and nutrition. These key activities are represented by three divisions: Pharmaceuticals, CropScience and Consumer Health. BMS Pfizer.jpg In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialise ELIQUIS, an investigational oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb’s long standing strengths in cardiovascular drug development and commercialisation with Pfizer’s global scale and expertise in this field. pfizer.com.au BILogo - Blue.jpg At Boehringer Ingelheim our purpose is simply to ‘Make More Health’ - for patients, our people and our community.
Boston_Scientific_Logo.jpg Boston Scientific’s mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Cordis-logo@2x.jpg Cordis, Cardinal Health offers a broad cardiovascular product range including BioFreedom the first drug coated stent, SMART family of self expanding peripheral stents; Outback Elite re-entry catheter; MynxGrip and ExoSeal vascular closure devices and coming soon InCraft AAA device a low profile, customisable at point of implant AAA treatment option. cordis.comEdwards.JPG Edward Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Drive by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. edwards.comMedtronic_1.jpg
Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. medtronic.com 8677 Melbourne Pathology Master_big logo.jpg Melbourne Pathology has been at the forefront of pathology practice for over 85 years. They understand the needs of their referring doctors and are committed to providing accurate and timely results, accessible pathologists and a quality, personalised customer service. MSD logo CONFIRMED 09042013.jpg For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. www.msd-australia.com.au Novartis.jpg Novartis is the largest Australian medicines company, improving the lives of more than 2.8 million patients across Australia and New Zealand. From generics to gene therapy, we are committed to accelerating patient access to life saving treatments. We are reimagining medicine by using innovative science and technology to address challenging healthcare issues and our rich pipeline has 200+ projects in development and an industry leading clinical trial footprint in Australia. Our unbossed, curious and inspired culture unites our 700 employees, it is what unleashes the power of our people and is at the heart of the work we do each day. www.novartis.com.auSanofi Genzyme.png Sanofi Genzyme is a pionerr in the development and delivery of transformative therapies for people affected by rare and debilitating diseases. Today, thanks to Sanofi Genzyme's enormous research efforts and successes, people benefit from disease-specific treatments for Gaucher disease, Pompe disease, Mucopolysaccharidosis type I and type II (MPS I and MPS II) and Fabry disease. https://www.sanofigenzyme.com.au/St Jude Medical CONFIRMED 15092014.jpg Turning What If Into Why Not™ At St. Jude Medical we are turning what if into why not by partnering with physicians, hospitals and insurers to save and improve millions of lives worldwide – while reducing health care costs for all. As a true leader, St. Jude Medical is committed to meeting or exceeding the high quality and safety expectations of our patients, customers and regulators. Quality is the shared belief that unites all 16,000 of our employees – it is built into everything we do and is the guiding principle behind every product we create. Headquartered in St. Paul, Minn., USA, St. Jude Medical is a global medical technology leader focused on six key treatment areas: Heart Failure – St. Jude Medical is pioneering heart failure disease management with innovative solutions that help reduce hospitalizations and improve the quality of life of patients. Arrhythmias – Our unparalleled product portfolio gives physicians the diagnostic, access, mapping and therapy solutions they need with designed integration for enhanced diagnosis and treatment of heart arrhythmias. Vascular Disease – Our breakthrough solutions guide health care providers in their treatment decisions – helping improve patient outcomes and provide cost savings opportunities. Chronic Pain – Patients around the world benefit from our transformational pain management technologies that enable them to return to work and live fuller, more satisfying lives. Neurological Diseases – As pioneers in the field, St. Jude Medical has developed cutting-edge neuromodulation technologies for the treatment of neurological diseases. http://www.sjm.com/australia |
